In addition, one in vivo study reported that FGF21 inhibits the nuclear factor kappa light chain enhancer of the activated B-cell (NF-κappaB) pathway in endothelial cells to improve atherosclerosis 52. The gene discussed is FGF21; the disease is atherosclerosis.